眼科新进展
眼科新進展
안과신진전
RECENT ADVANCES IN OPHTHALMOLOGY
2000年
1期
5-9
,共5页
张华%郭绒霞%孙乃学%王峰%张道过%王彤%孙健%杨振国%胡海涛%任惠民%刘勇
張華%郭絨霞%孫迺學%王峰%張道過%王彤%孫健%楊振國%鬍海濤%任惠民%劉勇
장화%곽융하%손내학%왕봉%장도과%왕동%손건%양진국%호해도%임혜민%류용
准分子激光角膜切削术%近视%近视散光
準分子激光角膜切削術%近視%近視散光
준분자격광각막절삭술%근시%근시산광
excimer laser photorefractive keratectomy%myopia%myopic astigmatism
目的评价准分子激光角膜切削术矫正近视的结果.方法我院自1996年9月到1997年10月,应用SVS APEX型(Summit Technology Inc.USA)准分子激光治疗仪,对168例近视患者(316只眼)行PRK手术,对其中的150例(260只眼,占84%)患者随诊至少3mo以上,最长1a;男68例(116只眼,占40.1%),女82例(144只眼,占59.9%).150例(260只眼)近视患者术前等值球镜屈光度为-1.25～-10.00D(-4.67D±1.63D),散光0～-2.00D(-0.33D±0.45D);按屈光度分为两组:A组(-1.25～-5.90D),B组(-6.00～-10.00D).结果 A组术后第10天,有68.9%(132/220)裸眼视力达到矫正视力,1、3、6和12mo分别为90%、96%、95%和94%.B组术后第10天,有35.9%(13/40)裸眼视力达到矫正视力,1、3、6和12mo分别为83%、87%、86%和84%.全组仅3只眼(0.64%)除外,均为0.5～1.0级的角膜上皮下雾状混浊,其出现的百分比手术后10d和1、3、6、12mo分别为32.9%、84.2%、62.4%、9.0%和2.8%.结论提示准分子激光角膜切削术治疗-10.00D以内的近视是一种安全有效、稳定性好、预测性强的方法,-6.00D以下效果更好.
目的評價準分子激光角膜切削術矯正近視的結果.方法我院自1996年9月到1997年10月,應用SVS APEX型(Summit Technology Inc.USA)準分子激光治療儀,對168例近視患者(316隻眼)行PRK手術,對其中的150例(260隻眼,佔84%)患者隨診至少3mo以上,最長1a;男68例(116隻眼,佔40.1%),女82例(144隻眼,佔59.9%).150例(260隻眼)近視患者術前等值毬鏡屈光度為-1.25～-10.00D(-4.67D±1.63D),散光0～-2.00D(-0.33D±0.45D);按屈光度分為兩組:A組(-1.25～-5.90D),B組(-6.00～-10.00D).結果 A組術後第10天,有68.9%(132/220)裸眼視力達到矯正視力,1、3、6和12mo分彆為90%、96%、95%和94%.B組術後第10天,有35.9%(13/40)裸眼視力達到矯正視力,1、3、6和12mo分彆為83%、87%、86%和84%.全組僅3隻眼(0.64%)除外,均為0.5～1.0級的角膜上皮下霧狀混濁,其齣現的百分比手術後10d和1、3、6、12mo分彆為32.9%、84.2%、62.4%、9.0%和2.8%.結論提示準分子激光角膜切削術治療-10.00D以內的近視是一種安全有效、穩定性好、預測性彊的方法,-6.00D以下效果更好.
목적평개준분자격광각막절삭술교정근시적결과.방법아원자1996년9월도1997년10월,응용SVS APEX형(Summit Technology Inc.USA)준분자격광치료의,대168례근시환자(316지안)행PRK수술,대기중적150례(260지안,점84%)환자수진지소3mo이상,최장1a;남68례(116지안,점40.1%),녀82례(144지안,점59.9%).150례(260지안)근시환자술전등치구경굴광도위-1.25～-10.00D(-4.67D±1.63D),산광0～-2.00D(-0.33D±0.45D);안굴광도분위량조:A조(-1.25～-5.90D),B조(-6.00～-10.00D).결과 A조술후제10천,유68.9%(132/220)라안시력체도교정시력,1、3、6화12mo분별위90%、96%、95%화94%.B조술후제10천,유35.9%(13/40)라안시력체도교정시력,1、3、6화12mo분별위83%、87%、86%화84%.전조부3지안(0.64%)제외,균위0.5～1.0급적각막상피하무상혼탁,기출현적백분비수술후10d화1、3、6、12mo분별위32.9%、84.2%、62.4%、9.0%화2.8%.결론제시준분자격광각막절삭술치료-10.00D이내적근시시일충안전유효、은정성호、예측성강적방법,-6.00D이하효과경호.
Objective To evaluate the efficacy and accuracy of photorefractive keratectomy(PRK) for myopia and myopic astigmatism.Methods SVS APEX PLUS excimer laser with a wave length of 193nm(Summit Technology Inc.Waltham,Mass,USA) was applied.Three hundred and sixteen myopic eyes of 168 patients were treated with PRK from Suptember 1996 to October 1997,and 260 eyes(84%) of 150 patients were followed-up for more than three month,including male 68(116 eyes,40.1%) and female 82(144 eyes,59.9%).The preoperative spherical equivalent refractive errors ranged from -1.25D to -10.00D(mean -4.67D± 1.63D),and astigmatism ranged from 0 to -2.00D(mean -0.33D±0.45D). The patients were divided into two groups according to the refraction:group A(from -1.25D to -5.90D) and group B(from -6.00D to -10.00D).The number of eyes in the two groups were 220 and 40,respectively.Results In group A,After 10 days,68.9% had the uncorrected visual acuity(UCVA) equal to or one line better or lower than the preoperative best corrected visual acuity(BCVA).After 1 ,3,6 and 12 months,90%,96%,95% and 94% had the UCVA equal to or one line better or lower than the preoperative BCVA,respectively.In group B,after 10 days,1,3,6 and 12 months,UCVA equal to or one line better or lower than the preoperative BCVA occurred in 35.9%,83.0%,87.0%,86.0% and 84.0% of the patients respectively. Most of the haze showed 0.5～1 grades except 3 eyes with the haze of 2 grade at 3 or 6 months and it changed to l and 0.5 grade respectively at one year.after 10 days and 1,3,6,12 months postoperatively,the corneal haze was noted in 32.9%,84.8%,62.8%,9.0%and 2.8% of the treated eyes respectively.Conclusion We found that the 193nm excimer laser PRK is a predictable,safe,stable,and effective refractive surgery for correcting myopia up to-10.00D in Chinese patients,and the effect is better in myopia lower than -6.00D.
